Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Improvement of Menopausal Signs by Isoflavones Derived from Sophorae fructus in Ovariectomized Female Rats and the Antioxidant Potentials in BV2 Cells

  • Published : 2005.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to determine if the isoflavones from Sophorae fructus (SISO) have potential clinical benefit in hormone replacement therapy (HRT) for the treat ment of menopausal signs, such as the levels of total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL) and follicle stimulating hormone (FSH). An additional aim was to present the potential antioxidant effect of SISO in a microglial cell line. For the animal model, the ovaries were removed from adult rats and the indicators of menopause were measured at the pre- and post-administration time points. Although no statistically significant correlation was found, SISO tended to decrease the TC level (p=0.15) and the FSH level (p=0.36), but to increase the HDL level (p=0.303).SISO (< 5${\mu}g$/mL) also exerted antioxidant activity on BV-2 microglial cells by inhibiting lipopolysaccharide-induced nitric oxide. This cytoprotective effect was confirmed by trypan blue staining, which was used to test for cellular damage from H$_2O_2$. In conclusion, this study highlights the anti-menopausal and antioxidant effect of SISO in an ovariectomized rat model, as well as in microglial cells, and provides new clinical targets for the screening of phytoestrogens as potential candidates for HRT in menopausal women.

Keywords

References

  1. Adlercreutz, H., Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab., 12, 605-623 (1998) https://doi.org/10.1016/S0950-351X(98)80007-4
  2. Beral, V., Banks, E., Reeves, G., and Appleby, P., Use of HRT and the subsequent risk of cancer. J. Epidemiol. Biostat., 4, 191-215 (1999)
  3. Brownson, D. M., Azios, N. G., Fuqua, B. K., Dharmawardhane, S. F., and Mabry, T. J., Flavonoid effects relevant to cancer. J. Nutr., 132, 3482S-3489S (2002) https://doi.org/10.1093/jn/132.11.3482S
  4. Cassidy, A., Bingham, S., and Setchell, K. D., Biologic effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60, 333-340 (1994) https://doi.org/10.1093/ajcn/60.3.333
  5. Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., Khandekar, J., Petrovitch, H., and McTiernan, A., Influence of estrogen plus progesterone on breast cancer and mammography in healthy postmenopausal women. JAMA, 289, 3243-3253 (2003) https://doi.org/10.1001/jama.289.24.3243
  6. Fitzpatric, L. A., Soy isoflavones: hope or hype? Maturitas, 44, 21-29 (2003) https://doi.org/10.1016/S0378-5122(02)00345-6
  7. Greendale, G. A., Lee, N. P., and Arriola, E. R., The menopause. Lancet, 353, 571-580 (1999) https://doi.org/10.1016/S0140-6736(98)05352-5
  8. Greendale, G. A., Reboussin, B. A., Hogan, P., Barnabei, V. M., Shumaker, S., and Barrett-Connor, E., Symptom relief and side effects of postmenopausal hormone results from the postmenopausal estrogen/progestin interventions trial. Obstet. Gynecol., 92, 982-988 (1998) https://doi.org/10.1016/S0029-7844(98)00305-6
  9. Joo, S. S., Won, T. J., and Lee, D. I., Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res., 27, 954-960 (2004) https://doi.org/10.1007/BF02975850
  10. Joo, S. S., Won, T. J., Kang, H. C., and Lee, D. I., Isoflavones extracted from Sophorae fructus upregulate IGF-1 and TGF- $\beta$ and inhibit osteoclastogenesis in rat bone marrow cells. Arch. Pharm. Res., 27, 99-105 (2004) https://doi.org/10.1007/BF02980054
  11. Kang, H. J., Ansbacher, R., and Hammoud, M. M., Use of alternative and complementary medicine in menopause. Intern. J. Gynecol. Obstet., 79, 195-207 (2002) https://doi.org/10.1016/S0020-7292(02)00297-7
  12. Kronenberg, F. and Fugh-Berman, A., Complementary and alternative medicine for menopausal systems: a review of randomized, controlled trials. Ann. Intern. Med., 137, 805- 813 (2002) https://doi.org/10.7326/0003-4819-137-10-200211190-00009
  13. Kuiper, G., Lemmen, J., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4264 (1998) https://doi.org/10.1210/en.139.10.4252
  14. Tavani, A. and La Vecchia, C., The adverse effects of hormone replacement therapy. Drugs Aging, 14, 347-357 (1999) https://doi.org/10.2165/00002512-199914050-00003
  15. Teresa, C., Cohick, W., and Raskin, I., Dietary phytoestrogens and health. Phytochemistry, 65, 995-1016 (2004) https://doi.org/10.1016/j.phytochem.2004.03.005
  16. Steer, T. E., Johnson, I. T., Gee, J. M., and Gibson, G.. R., Metabolism of the soybean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br. J. Nutr., 90, 635-642 (2003) https://doi.org/10.1079/BJN2003949
  17. Wuttke, W., Jarry, H., Becker, T., Schultens, A., Christoffel, V., Gorkow, C., and Seidlova-Wuttke, D., Phytoestrogens: endocrine disruptors or replacement for hormone replacement therapy? Maturitas, 44, S9-S20 (2003) https://doi.org/10.1016/S0378-5122(02)00344-4